Top

Reactions Weekly

Published in:

01-11-2022 | Hepatitis A | Case report

Pembrolizumab

Hepatitis: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Niederberger P, et al. Oncological emergencies with special consideration of the side effects of checkpoint inhibitors. [German]. Notfall und Rettungsmedizin 24: 963-972, No. 6, 2021. Available from: URL: http://doi.org/10.1007/s10049-020-00811-7 [German; summarised from a translation]

Title: Pembrolizumab
Hepatitis: case report
Publication date: 01-11-2022
Publisher: Springer International Publishing
Keywords: Hepatitis A
Hepatitis
Urothelial Cancer
Urothelial Cancer
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-27281-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Hepatitis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Insufficient compliance with valproate prescribing conditions in France

Multiple drugs

Methylprednisolone

Nafcillin/prednisone/sarilumab

Multiple drugs

Methylprednisolone/prednisone